|
VII. CURRENT STUDIES ON DOXEPIN
Topical
Doxepin Cream is Effective in Relieving Severe
Pruritus Caused by Burn Injury:
A Preliminary Study
Robert H.
Demling, M.D.; Leslie De Santi, R.N.
From the
Burn Center
Brigham and Women's Hospital
Harvard Medical School
Boston, MA
|
Abstract: We studied the
effect of a potent topical histamine H1 and H2 receptor
blocker, doxepin, on sev ere burn wound pruritus. We compared
the response of doxepin cream in 20 patients with healed
itching burn wounds, using the standard of care, which
included oral antihistamines, skin moisturizers, and
sedatives. The patients (all outpatients) were first assessed
as to the degree of itching using the 0 to 10 pain scale with
an initial assessment and a take-home chart for a seven-day
period after which all patients were placed on the topical
doxepin alone, and a daily pruritus assessment was made for
seven days. At the end of the doxepin-treatment period, wounds
were assessed, after which the previous standard of care was
resumed. The degree of pruritus decreased significantly with
the use of doxepin cream, decreasing from a value of 7±2 on
standard care to a value of 3±1 with the doxepin cream. The
response was noted within 15 minutes, and no tachyphylaxis was
noted. We also noted a significant decrease in wound erythema.
Some somnolence was noted in 20 percent of patients, which
decreased with two to three days of doxepin use. The degree of
itching and degree of wound erythema returned to pre-doxepin
levels with a return to standard care therapy. We concluded
that a topical doxepin cream is effective in decreasing wound
pruritus in burn patients with results superior to oral
antihistamines, skin moisturizers, and sedatives.
Wounds 2001:13(6);
210-215.
|
Topical
Doxepin
significantly decreases
itching and erythema in
the healed burn wound
Robert
Demling, M.D.; Leslie De Santi, R.N.
Burn Center
Brigham & Women's Hospital
Boston, MA
|
Abstract: Severe
itching, accompanied by erythema, is a common and
incapacitating problem in the healed burn wound. Itching is
most common in a partial thickness wound requiring about 3
weeks to heal. Increased release of histamine from local wound
mast cells and/or increased sensitivity of sensory nerves to
local histamine release, is considered a major causative
factor. The current standard approach for itch, which consists
of oral antihistamines, skin moisturizers and sedatives, is
often ineffective. Doxepin is a trycyclic compound found to
have extremely potent antihistamine properties. A 5% doxepin
cream is used to control the histamine induced itch of atopic
dermatitis, urticaria and other pruritic skin disorders.
Our purpose was to test the efficacy
of doxepin cream in controlling post burn itch compared to a
more standard care, in outpatients with healed itching burn
wounds. The study was continued over a 3 month period or until
the itch ceased. A (0-10) itch scale, 10 being the worst and a
(0 to 3) erythema scale, 3 being the worst, were used in this
randomized prospective trial.
We found that itch and erythema,
which were 5±2 and 2±1 with standard care decreased
significantly to 2±1 and 1±.5 respectively, for the length
of the study period with the Doxepin cream. Also, itching
ceased in 50% of patients, using doxepin cream before the 3
month period compared to only 10% using the oral
antihistamines. Mild and transient somnolence was seen in 15%
of patients using the doxepin cream, compared to 100% of
patients using standard care.
We can conclude that the 5% doxepin
cream significantly decreases itching and erythema, in the
healed burn wound, compared to oral antihistamines.

|